NOXRED1: A Potential Drug Target and Biomarker (G122945)

Target Name: NOXRED1

NCBI ID: G122945

Other Name(s): NADP dependent oxidoreductase domain containing 1 | NOXRED1 variant 1 | NXRD1_HUMAN | C14orf148 | NADP dependent oxidoreductase domain containing 1, transcript variant 1 | Pyrroline-5-carboxylate reductase-like protein C14orf148 | pyrroline-5-carboxylate reductase-like protein C14orf148 | NADP-dependent oxidoreductase domain-containing protein 1

NOXRED1: A Potential Drug Target and Biomarker

NAD+ (nicotinamide adenine dinucleotide) is a crucial coenzyme found in all living cells that plays a pivotal role in various cellular processes. It is a small molecule that has been linked to a wide range of physiological processes, including DNA replication, metabolism, and cellular signaling. NAD+ has also been recognized as an attractive drug target due to its unique structure and its ability to modulate various cellular processes. One of the well-known NAD+-dependent enzymes is NOXRED1, which is a protein that contains the NAD+-dependent oxidoreductase domain.

In this article, we will discuss NOXRED1, its function, and potential as a drug target and biomarker.

Function of NOXRED1

NOXRED1 is a protein that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It is a 21-kDa enzyme that catalyzes the NAD+-dependent oxidoreductase reaction, which involves the transfer of a electrons from NAD+ to a reduced molecule such as FAD or XML. This reaction is critical for the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism.

NOXRED1 is a critical enzyme for the regulation of cellular processes that require NAD+. It has been shown to play a role in various cellular signaling pathways, including the regulation of cell proliferation, differentiation, and survival. NOXRED1 has also been shown to play a role in the regulation of DNA replication and metabolism, as well as the regulation of cellular signaling pathways that are dependent on NAD+.

Potential as a Drug Target

NOXRED1 has been identified as a potential drug target due to its unique structure and its ability to modulate various cellular processes. The NAD+-dependent oxidoreductase reaction, which is catalyzed by NOXRED1, can be inhibited by various drugs, including small molecules, peptides, and antibodies. This makes NOXRED1 an attractive target for drug development due to its high specificity and its ability to modulate a wide range of cellular processes.

In addition to its potential as a drug target, NOXRED1 has also been shown to be a potential biomarker for various diseases. The NAD+-dependent oxidoreductase reaction, which is catalyzed by NOXRED1, has been shown to be affected in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Therefore, the inhibition of NOXRED1 has been shown to be a promising approach for the treatment of these diseases.

Potential as a Biomarker

NOXRED1 has also been shown to be a potential biomarker for various diseases. The NAD+-dependent oxidoreductase reaction, which is catalyzed by NOXRED1, has been shown to be affected in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Therefore, the inhibition of NOXRED1 has been shown to be a promising approach for the treatment of these diseases.

Despite its potential as a drug target and biomarker, the inhibition of NOXRED1 has not been fully understood. However, studies have shown that the inhibition of NOXRED1 can be used as a diagnostic tool for various diseases, including cancer and neurodegenerative diseases.

Conclusion

In conclusion, NOXRED1 is a protein that is expressed in various tissues and cells and plays a critical role in the regulation of various cellular processes, including cell signaling, DNA replication, and metabolism. Its unique structure and its ability to modulate various cellular processes make it an attractive target for drug development. Additionally, the inhibition of NOXRED1 has been shown to be a potential biomarker for various diseases, including cancer and neurodegenerative diseases. Further research is needed to fully understand the function of NOXRED1 and its potential as a drug target and biomarker.

Protein Name: NADP Dependent Oxidoreductase Domain Containing 1

Functions: Probable oxidoreductase

More Common Targets